tirzepatide vs semaglutide weight loss trials Tirzepatide is finally here – what's the big deal? – GP Voice New study result 🚨 Tirzepatide

Per publicly available announcements, the FDA issued more than 50 warning letters to GLP-1 compounders and manufacturers in September 2025, followed by 30 additional warning letters to telehealth firms in early 2026, targeting false or misleading marketing claims about compounded GLP-1 products

Patients should promptly report any symptoms such as a lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath

The GI side effects that plague so many semaglutide users, the nausea, the bloating , the constipation, the diarrhea, are not random bad luck

Low self-esteem correlates with mental health issues such as depression and anxiety

The active ingredients, semaglutide and tirzepatide, are FDA-approved in commercial formulations such as Wegovy, Ozempic, Mounjaro, and Zepbound

For those just beginning to explore these compounds, the getting started with peptides guide provides a solid foundation, and the common peptide mistakes beginners make article helps avoid early pitfalls